Ionis Pharmaceuticals | IONS - Debt



Ionis Pharmaceuticals reported $1.42B in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Adcock Ingram Holdings ZAR 969.4M 688.86M Dec/2024
Agios Pharmaceuticals USD 48.76M 48.76M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Arrowhead Research USD 388.24M 21.18M Mar/2025
Astellas Pharma JPY 831.43B 83.94B Mar/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Celltrion KRW 2.22T 24.87B Mar/2025
Cspc Pharmaceutical CNY 507.33M 118.46M Dec/2024
Divis Laboratories Ltd 40M 40M Mar/2025
Exelixis USD 179.84M 179.84M Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
Kangmei Pharma CNY 221.82M 958.68M Mar/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 2.14M 144K Dec/2024
Moderna USD 741M 4M Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Neurocrine Biosciences USD 439.1M 8.4M Jun/2025
Novartis USD 31.27B 12M Mar/2025
OPKO Health USD 395.74M 23.66M Jun/2025
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Pharma Mar EUR 51.4M 405K Jun/2025
PTC Therapeutics USD 286.01M 2.12B Jun/2025
Qiagen NV USD 1.44B 35.7M Jun/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tilray USD 351.72M 15.26M Nov/2024
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025
Zz Pientze Pharmaceu 1.12B 70.31M Mar/2025